PMID- 35464259 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 15 DP - 2022 TI - The Relationship Between Depression and Multifactorial Control and Microvascular Complications in Vietnamese with Type 2 Diabetes Mellitus Aged 30-60 Years. PG - 1185-1195 LID - 10.2147/DMSO.S354443 [doi] AB - BACKGROUND: Depression is a common mental disorder in people with type 2 diabetes mellitus (T2DM). Depression and T2DM have a reciprocal interaction through many factors, of which the most important is the multifactorial control and microvascular complications of T2DM. AIM: This research aims to determine the rate of depression and the association between depression and multifactorial control and microvascular complications in patients with T2DM aged 30-60 years in Vietnam. METHODS: A cross-sectional and descriptive study was conducted on 231 outpatients with T2DM at Bach Mai hospital, Hanoi, Vietnam. Depression severity was measured with the Patient Health Questionnaire-9 (PHQ-9). RESULTS: The rate of depression in patients with T2DM aged 30-60 years was 16.9% (in which, the rate of mild depression was 15.2% and moderate depression was 1.7%; no serious depression). The prevalence of depression was higher in female patients than in male patients (p = 0.049). There is a statistically significant difference in the rate of depression by age, duration of diabetes, and treatment method for type 2 diabetes. Poor HbA1c control and microvascular complications increase the risk of depression (OR = 2.37; 95% CI 1.11-5.02, p = 0.033 and OR = 2.62; 95% CI 1.15-5.93, p = 0.027, respectively). When the multivariate analysis was performed, it was shown that sex, treatment for glycemic control, and microvascular complications had a statistically significant influence on PHQ-9 score. CONCLUSION: In Vietnam, there are 16.9% of patients with T2DM aged 30-60 years suffer from depression. Poor HbA1c control, the presence of microvascular complications, and without antihyperglycemic treatment increase the risk of developing depression. CI - (c) 2022 Dinh Le et al. FAU - Dinh Le, Tuan AU - Dinh Le T AUID- ORCID: 0000-0003-2633-583X AD - Center of Emergency, Critical Care Medicine and Clinical Toxicology, Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam. AD - Department of Rheumatology and Endocrinology,Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam. FAU - Huy Duong, Hoang AU - Huy Duong H AUID- ORCID: 0000-0002-9125-6006 AD - Department of Neurology, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam. FAU - Thi Nguyen, Ly AU - Thi Nguyen L AD - Department of Internal Medicine, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam. AD - Postgraduate Student, Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam. FAU - Phi Thi Nguyen, Nga AU - Phi Thi Nguyen N AD - Department of Rheumatology and Endocrinology,Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam. FAU - Tien Nguyen, Son AU - Tien Nguyen S AUID- ORCID: 0000-0002-3220-234X AD - Department of Rheumatology and Endocrinology,Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam. FAU - Van Ngo, Manh AU - Van Ngo M AD - Postgraduate Training Management Department, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam. LA - eng PT - Journal Article DEP - 20220418 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC9031987 OTO - NOTNLM OT - depression OT - microvascular complications OT - multifactorial control OT - type 2 diabetes mellitus aged 30-60 years COIS- The authors declared no potential conflicts of interest concerning the research, authorship, and/or publication of this article. EDAT- 2022/04/26 06:00 MHDA- 2022/04/26 06:01 PMCR- 2022/04/18 CRDT- 2022/04/25 05:30 PHST- 2021/12/24 00:00 [received] PHST- 2022/04/01 00:00 [accepted] PHST- 2022/04/25 05:30 [entrez] PHST- 2022/04/26 06:00 [pubmed] PHST- 2022/04/26 06:01 [medline] PHST- 2022/04/18 00:00 [pmc-release] AID - 354443 [pii] AID - 10.2147/DMSO.S354443 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2022 Apr 18;15:1185-1195. doi: 10.2147/DMSO.S354443. eCollection 2022.